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In multiple sclerosis (MS) and other neuroinflammatory diseases, monocyte-derived cells
(MoCs) traffic through distinct central nervous system (CNS) barriers and gain access to
the organ parenchyma exerting detrimental or beneficial functions. How and where these
MoCs acquire their different functional commitments during CNS invasion remains
however unclear, thus hindering the design of MS treatments specifically blocking
detrimental MoC actions. To clarify this issue, we investigated the distribution of iNOS+
pro-inflammatory and arginase-1+ anti-inflammatory MoCs at the distinct border regions
of the CNS in a mouse model of MS. Interestingly, MoCs within perivascular parenchymal
spaces displayed a predominant pro-inflammatory phenotype compared to MoCs
accumulating at the leptomeninges and at the intraventricular choroid plexus (ChP).
Furthermore, in an in vitro model, we could observe the general ability of functionally-
polarized MoCs to migrate through the ChP epithelial barrier, together indicating the ChP
as a potential CNS entry and polarization site for MoCs. Thus, pro- and anti-inflammatory
MoCs differentially accumulate at distinct CNS barriers before reaching the parenchyma,
but the mechanism for their phenotype acquisition remains undefined. Shedding light on
this process, we observed that endothelial (BBB) and epithelial (ChP) CNS barrier cells can
directly regulate transcription of Nos2 (coding for iNOS) and Arg1 (coding for arginase-1)
in interacting MoCs. More specifically, while TNF-a+IFN-g stimulated BBB cells induced
Nos2 expression in MoCs, IL-1b driven activation of endothelial BBB cells led to a
significant upregulation of Arg1 in MoCs. Supporting this latter finding, less pro-
inflammatory MoCs could be found nearby IL1R1+ vessels in the mouse spinal cord
upon neuroinflammation. Taken together, our data indicate differential distribution of pro-
and anti-inflammatory MoCs at CNS borders and highlight how the interaction of MoCs
with CNS barriers can significantly affect the functional activation of these CNS-invading
MoCs during autoimmune inflammation.
Keywords: macrophage, blood-brain barrier, cell trafficking, iNOS - inducible nitric oxide synthase, arginase 1
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Central nervous system (CNS) barriers comprise cellular and
molecular specializations which limit the traffic of pathogens
and of blood-borne immune cells toward the organ
parenchyma (1). Tight barriers are present at the level of the
leptomeningeal vasculature within the subarachnoid space, of
the blood-cerebrospinal fluid (CSF) barrier around the choroid
plexus (ChP), and of the blood-brain barrier (BBB) in CNS
microvascular endothelial cells (2). Passage through these CNS
gateways leads to cells accumulating from the BBB in the
perivascular space, from the blood-CSF barrier and the
leptomeningeal vessels in the cerebrospinal fluid (CSF) and
the subarachnoid space (2). These anatomical compartments
are separated from the CNS parenchyma by a second
“checkpoint” mechanism constituted by the glia limitans (3, 4).
During neuroinflammatory conditions such as multiple sclerosis
(MS), different immune cells including monocyte-derived cells
(MoCs) cross these barriers and reach the CNS parenchyma,
where they guide disease progression (5). This multifocal passage
of MoCs through CNS barriers is also a pathological hallmark of
experimental autoimmune encephalomyelitis (EAE), a widely-used
animal model of MS-like CNS autoimmunity (6).
In both MS and EAE, MoCs are the most abundant immune
cells found within inflammatory lesions (7, 8). In the mouse,
MoCs arise from circulating Ly6ChighCX3CR1low monocytes and
show fast CCR2-mediated recruitment to inflamed tissues (9,
10). Following CNS infiltration, MoCs exert a wide array of
functions ranging from damaging pro-inflammatory to tissue
repairing anti-inflammatory actions (11–13).
The remarkable plasticity of MoCs originates from the
dynamic integration of numerous local signals (14), with pro-
and anti-inflammatory cells characterized by distinct metabolic
states and by differential regulation of phenotypic markers (11).
Among these, expression of the enzymes inducible nitric oxide
synthase (iNOS) and arginase-1 is commonly used as signature
marker for MoC pro- and anti-inflammatory polarization,
respectively (15). These two proteins utilize L-arginine as
substrate for the production of cytotoxic nitric oxide and
citrulline (iNOS), or urea and ornithine (arginase-1) with key
tissue repair properties (16).
By visualizing the expression of distinct reporter proteins
under the control of Nos2 and Arg1 promoters in iNOS-
tdTomato x Arginase-EYFP mice, we have recently described
the functional evolution of CNS-invading MoCs in the EAE
model (17). During disease development, CCR2+iNOS+ MoCs
(MiNOS) formed inflammatory CNS lesions, progressively
increased arginase-1 expression (MiNOS/Arginase intermediates)
and finally switched their phenotype toward an iNOSnegative-
arginase-1+ state (MArginase). This transition was paralleled by the
distinct CNS infiltration of MArginase cells that did not previously
express iNOS (17). Notably, even before reaching the CNS
parenchyma, MoCs accumulating at CNS barriers could
display a complete functional specification which likely
contributes to the disease evolution (17).
However, the polarizing factors and the sub-anatomical CNS
compartments where MoCs acquire their phenotype are notFrontiers in Immunology | www.frontiersin.org 2known. Furthermore, whether pro- and anti-inflammatory
MoCs are preferentially recruited at specific CNS gateways
remains unclear. This missing information hinders the design
of therapeutic interventions potentially blocking the invasion
and activation of cytotoxic MoCs during neuroinflammation.
To tackle this problem, we here assessed the anatomical
routes of MoCs migration to the CNS and investigated
whether their interaction with distinct CNS barriers regulates
the functional polarization of invading MoCs.
Notably, in the EAE model we could observe the presence of
iNOS+ and arginase-1+ MoCs within all CNS border areas, with
barrier-specific differences showing for instance higher presence
of pro-inflammatory MiNOS cells compared to transitional
MiNOS/Arginase cells at perivascular spaces of the BBB. In
parallel, an in vitro model revealed that functionally-polarized
MoCs are in principle able to migrate through the blood-CSF
barrier of the ChP, together suggesting that the ChP could
constitute a CNS access gateway and a polarization site for
both pro- and anti-inflammatory MoCs.
Secondly, we assessed whether the interaction with CNS
barriers would directly influence the functional state of
trafficking MoCs. Interestingly, we observed that IFN-g-
stimulated barrier cells induced a significant upregulation of
Nos2 in interacting MoCs, while Arg1 induction appeared
dependent on IL-1b stimulation of BBB cells. IL-1b signaling
at the BBB influenced the phenotype of invading MoC also in
vivo, as shown by analysis of MoCs around IL1R1+ BBB
endothelial cells in animals suffering from EAE.
Taken together, our data indicate how the local access
gateways and microenvironments utilized by MoCs to access
the CNS parenchyma substantially affect their migration and
functional specification during autoimmune CNS inflammation.MATERIAL AND METHODS
Animals
C57BL/6J mice were purchased from Janvier (Genest Saint Isle,
France). Arginase EYFP mice were originally purchased from
The Jackson Laboratory, iNOS-tdTomato were kindly provided
by Prof. Alain Bessis (ENS Paris, France); CCR2-RFP x CX3CR1-
GFP mice were a gentle gift of Dr. Israel F. Charo (UCSF, USA).
VE-cadherin-GFP mice were produced and donated by Prof.
Dietmar Vestweber (Max Planck Institute Münster, Germany).
Mice were housed in individually ventilated cages under specific
pathogen-free conditions. Animal procedures were performed in
accordance with the Swiss legislation on the protection of
animals and were approved by the veterinary office of the
Canton of Bern, Switzerland.
Active Experimental Autoimmune
Encephalomyelitis (aEAE) Induction
aEAE was induced by injection of myelin oligodendrocyte
glycoprotein peptide 35-55 (MOG35-55 peptide, 200 µg per
animal, Genscript, USA) and complete Freund’s adjuvant
(prepared from Incomplete Freund’s Adjuvant, Santa CruzApril 2021 | Volume 12 | Article 666961
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Tubercolosis, Difco). Briefly, an emulsion of MOG35-55 and
CFA was injected subcutaneously in mouse flanks and at the
tail base at day 0; in addition, 300 ng of pertussis toxin (List
Biological Laboratories, Campbell, CA, USA) was injected
intraperitoneally at day 0 and day 2. Immunized mice were
weighted and disease development scored daily according to a
previously established system (18). Four time points were
defined for analysis: weight loss (animals presenting a 3-5%
loss of weight shortly preceding clinical symptoms), day of
clinical onset (animals showing a limp tail and partial
weakening of hind limbs), symptomatic peak of disease
(animals presenting strong hind limb paraparesis or full
paraplegia, 3-4 days after EAE onset), and remission (animals
showing slight hind limb paraparesis after having displayed hind
leg paraplegia, 7-8 days after disease onset).
Brain Isolation and Vibratome Sections
Mice were sacrificed and transcardially perfused with 2%
paraformaldehyde (PFA, Merk Darmstadt, Germany) in
Dulbecco´s phosphate- buffered saline (DPBS, Gibco, Paisley,
UK); isolated brains were post-fixed in 2% PFA overnight and
were embedded in 2% low-melt agarose (Sigma-Aldrich, St. Louis,
MO, USA) in DPBS. Brains were sliced coronally at a thickness of
100µm, using a vibratome (VT1000S, Leica Biosystems, Muttenz,
Switzerland) at a speed of 0.65 mm/s and a frequency of 80Hz. The
samples were collected in ice cold DPBS.
Spinal Cord Isolation and Cryostat
Sections
Mice were sacrificed and transcardially perfused with 4%
paraformaldehyde (PFA, Merk Darmstadt, Germany) in
Dulbecco´s phosphate- buffered saline (DPBS, Gibco, Paisley,
UK); isolated spinal cords were post-fixed in 4% PFA overnight,
left for 3 days in 30% sucrose (Sigma-Aldrich, St. Louis, MO,
USA) diluted in DPBS and then frozen at -80°C in O.C.T.
(Tissue-Tek). 20 to 40 µm spinal cord longitudinal sections
were cut using a cryostat (HM550, Thermo Fisher).
Immunofluorescence Stainings of CNS
Tissue
For staining of ChP sections, vibratome-cut free-floating brain
slices were initially washed with 1x Tris-Buffered saline (TBS),
containing 10x TBS - 50mM Trizma Base (Sigma-Aldrich, St.
Louis, MO, USA), 150mM NaCl (Sigma-Aldrich, Buchs,
Switzerland) and 1mM CaCl2 x 2H2O (Sigma-Aldrich, St.
Louis, MO, USA), pH 7.4. Slices were incubated with blocking
buffer containing TBS with 5% skimmed milk (Rapilait, Migros,
Switzerland), 0.3% Triton X-100 (Sigma-Aldrich, St. Louis, MO,
USA) and 0.04% NaN3 (Fluka Chemie, Buchs, Switzerland), pH
7.4, for 2h at room temperature (RT). To stain the blood vessels,
we made use of the MEC13.3 antibody (anti-PECAM-1/CD31,
rat IgG2a, home-made), prepared in blocking buffer and
incubated overnight at 4°C on a rocker. After rinsing 3 x
5 min with 1x TBS, a secondary Cy5-conjugated AffiniPure
donkey anti-rat IgG (H+L) (1:200, stock of 0.5 mg/ml, JacksonFrontiers in Immunology | www.frontiersin.org 3ImmunoResearch Laboratories, West Grove, PA, USA, catalog
number 712-175-153) was diluted in blocking buffer and applied
to the sections for 2h at RT. The slices were incubated with DAPI
(1:5000, 1mg/ml stock, AppliChem, Darmstadt, Germany),
diluted in 1x TBS for 20 min at RT. After washing and drying,
the slices were mounted with Mowiol 4-88 (Aldrich, St Louis,
MO, USA).
For staining of cryostat-cut spinal cord sections, slices were
initially fixed with 100% ice cold acetone at −20°C for 10min and
dried before being reconstituted with 1x Tris-Buffered saline
(TBS), containing 10x TBS (see above). We blocked unspecific
antibody binding with 10% goat or donkey serum containing
0.1% Triton (Sigma-Aldrich, St. Louis, MO, USA) diluted in TBS
for 1h at RT. For primary antibody stainings, we used rabbit anti-
laminin (Dako, stock 3.8mg/ml, 1:1000), and goat anti IL1R1
(polyclonal IgG, R&D Systems, stock 0.2mg/ml, 1:100)
antibodies prepared in 2% goat or donkey serum, respectively,
containing 0.1% Triton in TBS and incubated overnight at 4°C.
After rinsing 3 x 5 min with 1x TBS, a secondary goat anti-rabbit
AF647 (Invitrogen, stock 2mg/ml, 1:500) or donkey anti-goat
AF647 IgG (H+L) (Jackson ImmunoResearch, 1:200) antibody
were applied in 2% goat or donkey serum for 2h at RT. Slices
were incubated with DAPI (1:5000 in TBS, 1mg/ml stock,
AppliChem, Darmstadt, Germany) for 10 min at RT. Slices
were mounted with Mowiol 4-88 (Sigma-Aldrich, St Louis,
MO, USA).
Density Analysis of MoCs at CNS Barriers
Z-stack images of CNS sections were acquired using a LSM800
confocal microscope (Zeiss) with 40x magnification, and
analyzed using Fiji (National Institute of Health, Bethesda,
MD, USA). Sections from C57BL/6J mice (both healthy and at
different time-points following EAE induction) were used to
infer tissue background and exclude artifacts. In sections from
iNOS-tdTomato x Arginase-EYFP and VE-cadherin x iNOS-
Tomato x Arginase-EYFP mice, expression of tdTomato and
EYFP was assessed manually and blindly. In sections from
CX3CR1-GFP x CCR2-RFP mice, numbers of RFP and GFP
expressing cells was assessed with a Fiji macro (Supplementary
Data 1). Cell density in CNS sections was calculated manually on
selected z-planes in image stacks using Fiji and extrapolated to
cells per mm2.
Bone Marrow-Derived Macrophage
Isolation and Cell Culture
The isolation, culture and stimulation of MoCs from the bone
marrow were performed according to previously established
protocols (17). Briefly, pelvis, tibia and femurs were isolated
from seven to twelve weeks-old C57BL/6J male mice. The bone
marrow was flushed using RPMI with glutamine (Gibco, Paisley,
UK) supplemented with 10% heat inactivated fetal bovine serum
gold (FBS, Gibco, Paisley, UK) and 100IU/ml penicillin-
streptomycin (Gibco, Paisley, UK) (henceforth called MoC
media). Following filtration through 100mm filters (Corning),
cells were incubated in 1ml of Ack lysing buffer (Gibco, Grand
Island, NY, USA) for 5 min on ice to deplete erythrocytes. AfterApril 2021 | Volume 12 | Article 666961
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5ng/ml recombinant mouse macrophage colony stimulating
factor (mCSF, 416-ML-500, R&D Biosystems, Minneapolis,
USA) for seven days at 37°C, 5% CO2, at a confluence of 2
million cells/ml, in non-treated tissue culture 100mm Petri
dishes (Greiner Bio-One, St. Gallen, Switzerland). For in vitro
migration experiments, at culture day seven, MoCs were
polarized for 48h towards: a pro-inflammatory profile (MLPS
+IFN-g), with 100ng/ml lipopolysaccharide from salmonella
enterica serotype typhimurium (LPS, Sigma-Aldrich, St. Louis,
MO, USA, catalog number L4516) and 10ng/ml recombinant
murine IFN-g (315-05, PeproTech, Rocky Hill, NJ, USA); an
anti-inflammatory phenotype (MIL-4+IL-13), with 10ng/ml
recombinant murine IL-4 (404-ML, R&D Biosystems,
Minneapolis, USA) and 10ng/ml IL-13 (413-ML-025, R&D
Biosystems, Minneapolis, USA); or were left unstimulated
(Munpolarized) in MoC medium containing mCSF. MoCs were
collected following 10min incubation in 0.05% Trypsin (25300-
054, Gibco, Paisley, UK) at 37°C.
mRNA Isolation
To isolate mRNA from MoCs, cells were washed with ice cold
sterile 1x DPBS and incubated for 5 min in 1ml TRIzol
(Invitrogen, Leicestershire, UK) or RNA-Bee (Amsbio, CS-
501B, UK) at RT. After cell scraping, a volume of 250ml
chloroform (Merck, Darmstadt, Germany) was added. The
cells were vigorously shaken for 15 seconds, left at RT for
5min, and centrifuged at a speed of 9300 x g for 15 min at
4°C. The top layer aqueous phase (containing RNA) was
carefully extracted and mixed gently with 500ml isopropanol
(Grogg Chemie, Stettlen, Switzerland). After 5min incubation
and 20min 13400 x g centrifugation at 4°C, the pellet was washed
once with ice cold 75% ethanol (Merck, Darmstadt, Germany).
After complete ethanol evaporation, the pellet was dissolved in
25ml ultrapure water and the mRNA concentration was
measured using a NanoDrop (Thermo Fisher Scientific,
Rochester, NY, USA). mRNA purity was assessed using the
260/280 nm and 260/230 nm ratios.
cDNA Synthesis and RTqPCR
To synthesize the complementary DNA (cDNA) from single
stranded mRNA via reverse transcription, we used SuperScript™
III Reverse Transcriptase cDNA synthesis kit (Invitrogen,
Carlsbad, CA, USA, 18080-051) according to manufacturer´s
instructions. Briefly, equal amounts of mRNA from each sample
were incubated with 50ng random hexamer primers and 1mM
dNTP Mix for 5min at 65°C. The reaction was then allowed to
cool on ice for 5min to allow primer binding. Afterwards, a
cDNA synthesis mix containing 10x first-strand buffer, 0.1M
DTT, 40IU/ml RNAseOUT (Invitrogen, Carlsbad, CA, USA,
catalog number 10777-019), and 200IU/ml reverse transcriptase
solution was added. The complementary DNA was catalyzed by
incubating the samples at 25°C (10min) and 50°C (50min) in a
PCR thermal cycler (Mastercycler X59s, Eppendorf, Hauppauge,
NY, USA). The reaction was inactivated at 70°C for 15 min and
allowed to cool at 4°C for 10min. To perform real time
quantitative PCR reaction (RTqPCR), we used Taykon™ LowFrontiers in Immunology | www.frontiersin.org 4Rox SYBR MasterMix dTTP blue (Eurogentec, Liege, Belgium)
according to manufacturer´s instructions. A total amount of
8.75ng cDNA per well was used (in a total volume of 20ul/well).
Each sample was tested in triplicates in MicroAmp™ Optical
384-well reaction plates (Applied Biosystems, Waltham,
Massachusetts, USA) using the Fast Real-Time PCR System
7500 (Applied Biosystems, Waltham, Massachusetts, USA).
Primer sequences are shown in Supplementary Table 1 and
the average CT values for each gene from three independent
experiments are provided in Supplementary Table 2. We used
the r ibosomal prote in S16 (S16) or hypoxanthine
phosphoribosyltransferase (Hprt) as reference genes, as
indicated in the respective figure legends. To determine the
relative change in gene expression of treated samples relative
to untreated controls, we calculated the mean cycle threshold
(Ct) value from triplicate samples of each condition for each
gene, and the 2-DDCt value was determined by the following
formula: 2-DDCt = 2 – Treated Sample (Mean Ct value Gene of interest –Mean
Ct value Reference gene) – Control Samples(Mean Ct value Gene of interest –Mean
Ct value Reference gene).
Primary Mouse Brain Microvascular
Endothelial Cells Culture
BBB endothelial cells were isolated from the cortex of six to
twelve weeks old C57BL/6J male mice according to a previously
established protocol (19). After isolation, the cells from one brain
were plated in two Matrigel- (Corning, New York, USA,
reference 356231) coated 35mm dishes (ibidi GmbH, Munich,
Germany) on a surface of 6.6 mm2 for live cell imaging
experiments or in three filters of 0.5mm pore size and 6mm
diameter (3421, Corning, New York, USA), coated with laminin
from Engelbreth-Holm-Swarm murine sarcoma basement
membrane (Sigma-Aldrich, St. Louis, MO, USA) and Matrigel
for migration assays. The cells were grown for seven days at 37°C,
10% CO2 in culture media containing Dulbecco´s modified eagle
medium (DMEM, Gibco, Paisley, UK) supplemented with 20%
FBS (Biowest, Nuaille, France), 2% sodium pyruvate (11360-039,
Gibco, Paisley, UK), 2%MEM non-essential amino acids (11140-
035, MEM NEAA, Gibco, Paisley, UK), 50µg/ml gentamycin
(15710-049, Gibco, Paisley, UK) and 1ng/ml basic fibroblast
growth factor (F0291, Sigma-Aldrich, St. Louis, MO, USA). For
the first 48h, the media was supplemented with 4µg/ml
puromycin (P9620, Sigma-Aldrich, St. Louis, MO, USA) to
prevent pericyte contamination. At culture day six, cells were
stimulated for 14h-20h with 20ng/ml recombinant murine IL-1b
(211-11B-10UG, PeproTech, Rocky Hill, NJ, USA) or with 5ng/
ml recombinant murine TNF-a (211-11B-10UG, PeproTech,
Rocky Hill, NJ, USA) + 100IU/ml IFN-g (315-05, PeproTech,
Rocky Hill, NJ, USA).
Primary Mouse Choroid Plexus Epithelial
Cells Culture
ChP epithelial cells were isolated, cultured and stimulated
according to a previously established protocol (20) with minor
adjustments. Specifically, six to twelve weeks old C57BL/6J male
mice were sacrificed and the ChP from the lateral and fourthApril 2021 | Volume 12 | Article 666961
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digestion at 37°C in 1x DPBS (Gibco, Paisley, UK) containing
0.1mg/ml pronase (Roche Mannheim, Germany), epithelial cells
were mechanically and enzymatically disaggregated from the
choroidal structure using warm 0.025% trypsin-EDTA (Gibco,
Paisley, UK) containing 12.5µg/ml DNAse I (Roche, Mannheim,
Germany). After stopping the enzymatic reaction, the cell
suspension was resuspended in ChP epithelial cells media
containing DMEM/F12 1:1 (Gibco, Paisley, UK), FBS 10%
(Gibco, Paisley, UK), 2mM glutamine (Gibco, Paisley, UK),
50µg/ml gentamycin (Gibco, Paisley, UK) and plated for 2h in
non-coated 35mm petri dishes (PD) (BD Biosciences, Franklin
Lakes, NJ, USA) at 37°C. This step allowed the detachment of
fibroblast and macrophages from epithelial cells. The cells were
resuspended in ChP epithelial cells media and were plated on
50µg/ml laminin (Roche, Mannheim, Germany) coated inverted
filters of 5mm pore size and 6mm diameter (Corning, New York,
USA, reference 3421) for 48h, following which the filters were
placed in a 24well plate (Thermo Fisher Scientific, Rochester,
NY, USA). To obtain a single monolayer, ChP epithelial cells
media supplemented with 5mg/ml human insulin (Sigma
Aldrich, St Louis, MO, USA), 10ng/ml hEGF (Peprotech,
Rocky Hill, NJ, USA), 2mg/ml hydrocortisone (Sigma, Buchs,
Switzerland) and 20mm cytosine arabinoside (Ara-C; Sigma, St.
Louis, MO, USA) was placed below the filter, in contact with the
cells. The apical side of the insert remained dry to prevent the
formation of double layer culture. At culture day six, epithelial
cells are stimulated whether with 10ng/ml TNF-a (PromoCell,
GmbH, Heidelberg, Germany) or with 100IU/ml IFN-g
(PeproTech, Rocky Hill, NJ, USA) for 16h. Unstimulated
epithelial cells were used as control conditions.
Live Cell Imaging Migration Experiment
In vitro live cell imaging of MoC interaction with BBB endothelial
cells was performed as previously described (21). Munpolarized,
MLPS+IFN-g and MIL-4+IL-13 macrophages were resuspended in
migration assay media (MAM) containing DMEM, 5% FBS,
4mM L-Glutamine (A2916801, Gibco, Paisley, UK) and 25mM
HEPES buffer solution (15630-056, Gibco, Paisley, UK) at a
concentration of 1 x 106 cells/ml. A total of 2 x 105 cells were used
per movie. Accumulation of Munpolarized, MLPS+IFN-g and MIL-4
+IL-13 macrophages on BBB endothelial cells in the flow chamber
occurred for an interval of 5 min, at a low shear pressure of 0.1
dyn/cm2, followed by an increase in the shear flow at
physiological levels of 1.5 dyn/cm2 for 25 min. The total
recording time was 30 min, with 10 seconds interval between
each frame. Image acquisition was performed using the phase
contrast at an inverted microscope (AxioObserver, Zeiss,
Feldbach, Switzerland) with a 10x objective. The image analysis
was performed using Fiji (National Institute of Health, Bethesda,
MD, USA). The number of arrested macrophages per condition
was assessed at 40 seconds after onset of physiological shear flow.
Two-Chamber Migration Assays
To assess MoC migration across BBB endothelial cells or ChP
epithelial cells monolayers under static condition, we used a
transwell system as previously described (20, 22). BBBFrontiers in Immunology | www.frontiersin.org 5endothelial cells and ChP epithelial cells cultured on filters as
described above were used at culture day seven after 16h cytokine
stimulation, whereas MoCs were used after 48h cytokine
stimulation. Following trypsinization from culture plates,
MoCs were labelled with 1mm CellTracker™ green dye
(CMFDA, C2925, Invitrogen, Rockford, IL, USA) at 37°C for
30 min. After labelling, MoCs were washed twice with 1x DPBS
and resuspended in MAM. For each condition, 2x105 MoCs
resuspended in 100ml MAM were added on the upper side of the
filter. Underneath the filter, 600ml MAM were added. Laminin-
coated empty filters were used as controls. MoCs were allowed to
migrate across BBB endothelial cells, ChP epithelial cells or
across matrigel or laminin coated empty filters for a period of
8h at 37°C, 10% CO2. At the end of the experiment, migrated
MoCs were collected from the bottom compartment and
CMFDA+ cells and counted using an Attune NxT flow
cytometer (Thermo Fisher Scientific, Rochester, NY, USA).
Later, the apical and basolateral sides of the filters were gently
washed three times with 1xDPBS and the filters were 1% PFA
fixed and stained with polyclonal rabbit anti-zona occludens-1
(ZO-1) antibody (61-7300, Invitrogen, Rockford, IL, USA) to
distinguish endothelial monolayer, or with monoclonal mouse
anti-human E-cadherin (610182, BD Biosciences, Franklin
Lakes, NJ, USA), to delineate the epithelial layer (see below).
Following fixation and staining, using a confocal microscope
(LSM800 Zeiss, Germany), we acquired 20mm z-stack images
starting from the upper side of each filter, with a 2mm interval.
For each filter, we acquired the z-stack images at five different
fields of view (FOV) (upper left, upper right, center, lower left,
lower right), to sample the entire filter area. After image
acquisition, using Fiji software, we quantified the number of
MoCs attached on the upper side of the filters (corresponding to
the luminal side of BBB endothelial cells, and to the basolateral
side of inverted ChP epithelial cells), using a custom-made
macro (Supplementary Data 1). We confirmed correct macro
function by manual quantification of at least 30 fields of view
from different filters. The quantification of MoCs undergoing
migration across monolayers and filters (on the abluminal side of
BBB endothelial cells, or on the apical side of ChP epithelial cells)
was performed manually. For each filter, the mean and the
standard error of the mean (SEM) of the number of BMDMs
from five different FOVs was used for final quantification.
In Vitro Interaction of MoCs With BBB
Endothelial and ChP Epithelial Cells and
G-CSF + GM-CSF Blocking Experiments
MoCs were isolated and differentiated for 8 days in the presence
of m-CSF (as described above). BBB endothelial cells and ChP
epithelial cells were isolated as described and grown for 7 days in
24 well plates, at a density of 2 brains/well for BBB endothelial
cells or 3.3 brains/well for ChP epithelial cells. At culture day six,
BBB endothelial cells were stimulated for 14h-16h with 20ng/ml
recombinant murine IL-1b (PeproTech, Rocky Hill, NJ, USA,
catalog number 211-11B-10UG) or with a mix of 5ng/ml
recombinant murine TNF-a (PeproTech, Rocky Hill, NJ, USA,
catalog number 211-11B-10UG) + 100IU/ml IFN-g (PeproTech,
Rocky Hill, NJ, USA, catalog number 315-05). In contrast, ChPApril 2021 | Volume 12 | Article 666961
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(PromoCell, GmbH, Heidelberg, Germany) or with 100IU/ml
IFN-g (PeproTech, Rocky Hill, NJ, USA). Unstimulated BBB
endothel ial cel ls/ChP epithel ial cel ls were used as
control conditions.
Before the interaction assay and following BBB endothelial
cells and ChP epithelial cells cytokine activation, the CNS barrier
models were washed thoroughly with 1xPBS (Gibco, Paisley,
UK) and MoCs were collected by 10min incubation in 0.05%
Trypsin (Gibco, Paisley, UK, reference 25300-054) at 37°C. A
total of 1.2 x 106 MoCs were resuspended in 500µl migration
assay media (DMEM, 5% FBS, 4mM L-Glutamine, 25mM
HEPES, 50µg/ml gentamycin) and added to BBB endothelial
cells or ChP epithelial cells containing wells.
For functional assays investigating the roles of factors released
by CNS in vitro barriers on macrophages polarization, prior to
the addition of MoCs, BBB endothelial cells/ChP epithelial cells
were incubated for 1h30-2h with neutralizing antibodies against
G-CSF (polyclonal goat IgG, AF-414-NA, R&D Systems), GM-
CSF (polyclonal goat IgG, AF-415-NA, R&D Systems), or with
isotype control (polyclonal normal goat IgG, AB-108-C, R&D
Systems) at a concentration of 10µg/ml per antibody. The
following mix of antibodies was used: 10µg/ml G-CSF + 10µg/
ml GM-CSF. The antibody mixes were further kept in the culture
throughout the 7h incubation of MoCs with BBB endothelial/
ChP epithelial cells.
Following the 7h incubation, MoCs were recovered from the
BBB endothelial cells/ChP epithelial cells containing wells via 3-4
rounds of resuspensions. Following 2x washing steps of both
BBB endothelial cells/ChP epithelial cells and MoCs, the cells
were further processed for mRNA isolation, and cDNA
synthesis. Lastly, we assessed the expression of Arg1, Tpi1,
Gpi1 genes in MoCs by means of RT-qPCR.
Incubation of MoCs With Recombinant
Proteins
Following isolation, culture and differentiation for 8 days, MoCs
were trypsinized, plated in 24-well plates at a concentration of
1.2x106 and incubated for 7h with 10ng/ml, 50ng/ml or 100ng/
ml of recombinant mouse GM-CSF or G-CSF proteins, at 37°C,
10% CO2. At the end of the experiment, the attached BMDMs
were washed 3x with 1xPBS and were further processed for
mRNA isolation, cDNA synthesis and RT-qPCR.
Immunofluorescence Staining of In Vitro
CNS Barrier Cells Cultured on Filters
BBB endothelial cells and ChP epithelial cells cultured on
Transwell filters (Corning, New York, USA, 3421) were fixed
with 1% PFA diluted in 1x DPBS for 10min at RT. After fixation
and removal from the inserts, the filters were washed three times
with 1x DPBS and incubated in blocking buffer containing 5%
skimmed milk (Rapilait, Migros, Switzerland), 0.3% Triton-X-
100 (Sigma-Aldrich, St Louis, MO, USA), 0.04% NaN3 (Fluka
Chemie, Buchs, Switzerland), pH 7.4 for 30min at RT. The cells
were incubated afterwards in primary antibodies for 1h at RT.
The fo l lowing pr imary an t ibod ie s were used forFrontiers in Immunology | www.frontiersin.org 6immunofluorescence staining: polyclonal rabbit anti-ZO-1
antibody (Invitrogen, Rockford, IL, USA, catalog number 61-
7300), monoclonal mouse anti-b-catenin (BD Biosciences,
Franklin Lakes, NJ, USA, catalog number 610154), monoclonal
mouse E-cadherin (BD Biosciences, Franklin Lakes, NJ, USA,
catalog number 610182), polyclonal rabbit anti-claudin-5
(Thermo Fisher Scientific, Rockford, IL, USA, catalog number
341600), monoclonal rat CD106 (clone 429 MVCAM.A, BD
Biosciences, 553329). Rat anti-mouse endothelial-selectin (E-
Selectin, clone 10E9), rat anti-mouse intracellular adhesion
molecule-1 (ICAM-1, clone 25ZC7), rat anti-mouse vascular
cell adhesion molecule-1 (VCAM-1, clone 9DB3), rat anti-
mouse vascular endothelial cadherin (VE-cadherin, clone
11D4) and rat anti-mouse junctional adhesion molecule-A
(JAM-A, clone BV12) antibodies were isolated from the
supernatants of hybridoma cultures in house. After 3x DBPS
washing steps, the samples were incubated in secondary
antibodies diluted in blocking buffer for 1h at RT, under light
protected conditions. The following secondary antibodies were
used: AF488 donkey anti-mouse IgG (H+L) (Invitrogen, Eugene,
OR, USA, catalog number A21202), AF647 goat anti-rabbit IgG
(H+L) (Invitrogen, Eugene, OR, USA, catalog number A21244),
Cy3-conjugated AffiniPure donkey anti-rat IgG (H+L) (Jackson
ImmunoResearch, West Grove, Pa, USA, catalog number 712-
165-150). Following nuclear staining with DAPI (1:5000, stock
concentration of 1mg/ml, AppliChem, Darmstadt, Germany) for
5 min at RT, the filters were washed 3x with 1x DPBS, placed on
glass slides (Thermo Scientific, Rochester, NY, USA) and
mounted with embedding medium Mowiol (Sigma-Aldrich, St
Louis, MO, USA).
Flow Cytometry Analysis of MoC Integrin
Expression
After 48h polarization (see above), MUnpolarized, MLPS+IFN-g and
MIL-4+IL-13 were detached from culture plates using 0.05%
trypsin/EDTA solution (Merck, Darmstadt, Germany) for
10 min at 37°C. After stopping the reaction with MoC media,
cells were washed with 1x DPBS and the Fc-receptors were
blocked on ice for 15 min (using anti-CD16/32, homemade
solution). The cells were then incubated with the following
antibodies diluted in 1x DPBS for 30 min at 4°C, in light-
protected conditions: PE-Cy7 conjugated anti-mouse CD11b
(clone M1/70, BioLegend, San Diego, CA, USA, catalog
number 101216); BV711 conjugated anti-mouse CD45 (clone
30-F11, Biolegend, San Diego, CA, USA, catalog number
103147); fluorescein isothiocyanate (FITC) conjugated anti-
mouse CD18 (b2) (clone M18/2, Invitrogen, Rockford, IL,
USA, catalog number 11-0181-82); APC-efluor 780-conjugated
anti-mouse CD29 (b1) (clone HMb1-1, Invitrogen, Rockford, IL,
USA, catalog number 47-0291-82), alexa fluor 647-conjugated
anti-mouse CD49d (a4) (BioRad, Hercules, CA, USA, catalog
number MCA 1230A647T), cell viability dye eFluor 506
(Invitrogen, Rockford, IL, USA, catalog number 65-0866-14).
Isotype control stainings served as controls. Samples were
acquired using an Attune NxT cytometer (Thermo Fisher
Scientific, Rochester, NY, USA). MUnpolarized, MLPS+IFN-g andApril 2021 | Volume 12 | Article 666961
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scattering, viability and CD11b+CD45+ expression. Analysis was
performed using the FlowJo™ software (version 10, Ashland,
OR, USA) and the relative mean fluorescence intensity (MFI)
was calculated for each antibody by subtracting the MFI of
antibody staining from the MFI of isotype control staining.
Statistics
Statistical analysis was performed using GraphPad Prism 8 or 9
software (La Jolla, CA, USA). All values are presented as mean ±
SEM. Asterisks indicate significant differences (∗p < 0.05, ∗∗p <
0.01 and ∗∗∗p < 0.001, ∗∗∗∗p < 0.0001). Unpaired T test was
used for the analysis of MiNOS, MArginase and MiNOS/Arginase cells
in the IL1R1+ and IL1R1negative vessel regions and for the analysis
of the percentage of Il1R1positive vessels in the parenchyma and
the meninges following validation of their normal distribution
(by Shapiro Wilk and Kolmogorov-Smirnov tests). One-way
ANOVA with Tukey’s multiple comparison test was used for
the following experiments: TEER measurements of BBB
endothelial cells and ChP epithelial cells, MoC integrin
expression by flow cytometry, Mean Fluorescence Intensity
assessment of VCAM-1, ICAM-1 and E-selectin expression on
BBB endothelial and ChP epithelial cells. MoC mRNA
expression of inflammatory and chemokine receptors genes,
quantification of CCR2+ and CX3CR1+CCR2negative cells in the
ChP, quantification of MiNOS, MArginase andMiNOS/Arginase cells in
the perivascular and meningeal space, MoC incubation with
recombinant G-CSF, GM-CSF proteins, MoC incubation with
BBB endothelial cells and with ChP epithelial cells, MoC
incubation with BBB endothelial cells/ChP epithelial cells in
the presence of G-CSF+GM-CSF blocking antibodies, mRNA
expression of Csf2, Csf3 in unstimulated and cytokine activated
BBB endothelial cells and ChP epithelial cells. Two-way ANOVA
with Tukey’s multiple comparison tests was used to assess
statistical significance in MoC migration assays with ChP
epithelial cells and BBB endothelial cells, both in presence and
absence of physiological shear flow.RESULTS
Differential Distribution of Polarized MoCs
at CNS Barriers During EAE
Upon autoimmune inflammation, CNS interfaces become
increasingly populated by tissue-invading MoCs (23, 24), some
of which display a complete functional polarization characterized
by the expression of iNOS and/or arginase-1 (17). Whether
MiNOS and MArginase MoCs accumulate equally at different
CNS gateways remains however unknown.
To quantify the presence of polarized MoCs at the distinct
CNS barriers we created triple transgenic VE-cadherin-GFP x
iNOS-tdTomato x Arginase-EYFP mice, a model in which VE-
cadherin+ endothelial junctions are visualized by GFP expression
whereas pro-inflammatory MiNOS and anti-inflammatory
MArginase cells are visualized by tdTomato and EYFP
expression, respectively (25). In addition, we performed pan-Frontiers in Immunology | www.frontiersin.org 7laminin staining of the tissue sections allowing us to identify
endothelial and parenchymal basement membranes and thus the
actual borders of the perivascular and subarachnoid spaces,
respectively. Our analysis revealed that, upon induction of
EAE, CNS vessels displayed preferential perivascular
accumulation of MiNOS cells, which occupied these spaces in
significant higher numbers than transitional MiNOS/Arginase cells
(Figures 1A–C). Conversely, leptomeningeal spaces revealed an
equal presence of MiNOS, MArginase and MiNOS/Arginase cells
(Figures 1A, B, D).
Leptomeningeal MoC accumulation can derive from local
extravasation of monocytes through meningeal vessels or from
CSF trafficking through the distal ChP (24). To visualize the
density of MoCs at the ChP, we first made use of CX3CR1-GFP x
CCR2-RFP mice, a model in which differential reporter
expression allows distinction of infiltrating CCR2+ MoCs from
long-lived CCR2negativeCX3CR1high resident macrophages (9). In
healthy animals, confocal analysis of thick ChP sections revealed
a minor presence of blood borne CCR2+ MoCs (26) and a high
number of ramified CX3CR1+ tissue resident macrophages
populating the ChP stroma (Figure 2A). During EAE
development, we could observe a significant increase in CCR2+
infiltrating cells in the ChP stroma (Figures 2B, C), suggesting
that this region allows CNS infiltration of MoCs during
autoimmune inflammation.
To assess the functional polarization of these CCR2+ MoCs,
we induced EAE in iNOS-tdTomato x Arginase-EYFP mice and
performed confocal analysis of thick brain sections, observing
equal presence of MiNOS, MArginase and MiNOS/Arginase cells in the
ChP stroma (Figures 2D, E). Nonetheless, compared to the high
cellular density observed at the other CNS barriers (Figure 1A),
only few polarized MoCs could be observed within the ChP
throughout disease development (Figure 2E).
Taken together, our data indicate that pro- and anti-
inflammatory MoCs are present at all CNS border areas during
EAE. However, these cells accumulate in different densities and
proportions at distinct CNS barriers, potentially indicating
preferential trafficking routes and diverse local molecular
activation of migrating MoCs.
Functional Characterization of Primary
CNS Barrier and MoC In Vitro Models
To study the differential dynamics of MoCs at the distinct CNS
barriers, we adopted an in vitro system comprising bone
marrow-derived macrophage cultures [to mimic MoCs),
primary mouse brain microvascular endothelial cells (to mimic
the BBB endothelial cells (19, 27)] and primary mouse ChP
epithelial cells [to mimic the blood-CSF barrier (20)], all isolated
according to well-established approaches.
BBB endothelial cells formed a confluent monolayer,
characterized by junctional localization of the adherens
junction proteins b-catenin and VE-cadherin and of the tight
junction proteins zona occludens-1 (ZO-1) and claudin-5
(Supplementary Figures 1A–D). To model neuroinflammatory
conditions, BBB endothelial cells were stimulated either with
interleukin-1b (IL-1b) or with tumor necrosis factor-a (TNF-a)April 2021 | Volume 12 | Article 666961
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the integrin-binding molecule intercellular adhesion molecule-1
(ICAM-1) was specifically upregulated upon IL-1b stimulation
as was the endothelial cell adhesion molecule E-selectin, while
expression of vascular cell adhesion molecule-1 (VCAM-1) was
not affected upon cytokine stimulation compared to
unstimulated BBB endothelial cells (Supplementary Figure
1E–J). As a measure of barrier integrity, we assessed trans-
endothelial electrical resistance (TEER) of the BBB endothelial
cells and observed a significant decrease of TEER following
cytokine stimulation compared to unstimulated conditions
(Supplementary Figure 1K).
To allow for side-by-side comparison of the BBB with the
blood-CSF barrier, ChP epithelial cells were isolated from theFrontiers in Immunology | www.frontiersin.org 8same mice that yielded BBB endothelial cells. ChP epithelial cells
displayed mature BSCFB characteristics as shown by the
junctional localization of E-cadherin, junctional adhesion
molecule-A (JAM-A) and b-catenin (Supplementary Figure
2A–C). To mimic local inflammation, ChP epithelial cells were
stimulated either with TNF-a or IFN-g (20). IFN-g stimulation
led to upregulation of ICAM-1 and VCAM-1 (Supplementary
Figures 2D–G). However, we found no increase in TEER across
cytokine-stimulated ChP epithelial cells (Supplemetary
Figure 2H).
To model MoCs trafficking through CNS barriers, we made
use of bone marrow-derived macrophage cultures and
implemented a stimulus-based nomenclature according to
suggestions by experts in the field (29). We kept cellsFIGURE 1 | Polarized MoC density in perivascular and leptomeningeal spaces during EAE. (A) Density of MiNOS, MArginase and MiNOS/Arginase cells in the perivascular
spaces and leptomeninges of VE-cadherin-GFP x iNOS-tdTomato x Arginase-EYFP mice induced with EAE (6 mice at day 3 after onset of the disease). Data
represented as mean ± SEM. Statistical analysis performed by one-way ANOVA with Tukey’s multiple comparisons test, p=0.0389, *p < 0.05. (B) Relative
percentage of the MiNOS, MArginase and MiNOS/Arginase cells shown in (A). Within perivascular spaces, a higher percentage of MiNOS cells are detected (Mean =
46.09%, SEM = 11.34) as compared to MArginase (Mean = 42.47%, SEM = 12.80) and MiNOS/Arginase (Mean = 11.44%, SEM = 3.46). In contrast, within the meninges,
a predominant population of MArginase (Mean = 33.24%, SEM = 3.23) and MiNOS/Arginase (Mean = 37.49%, SEM = 0.97) was found, as compared to MiNOS (Mean =
29.27%, SEM = 2.91). No statistically significant differences were observed, one-way ANOVA with Tukey´s multiple comparisons test. (C, D) Representative confocal
images of spinal cord perivascular spaces (C) and leptomeninges (D) of VE-cadherin-GFP x iNOS-tdTomato x Arginase-EYFP mice induced with EAE (3 days after
disease onset). tdTomato indicates MiNOS, EYFP/GFP MArginase cells and VE-cadherin of endothelial cell junctions. Staining with DAPI reveals nuclei, immunostaining
with anti-laminin antibody reveals the perivascular and meningeal extracellular matrix. Arrowheads highlight MArginase cells and arrows indicate MiNOS cells in the
perivascular space (C) and meninges (D). Scale bar, 30 mm.April 2021 | Volume 12 | Article 666961
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(MLPS+IFN-y) or anti-inflammatory phenotype (MIL-4+IL-13),
observing significant upregulation of pro-inflammatory genes
including Nos2 and anti-inflammatory genes including Arg1,
respectively (Supplementary Figures 3A, B and Supplementary
Table 2) (17).
Secondly, we assessed the expression of chemokine
receptors that might affect cell migration. We observed anFrontiers in Immunology | www.frontiersin.org 9equal expression of Ccr5 in all conditions, an increase of Ccr1
expression in MLPS+IFN-y and MIL-4+IL-13 compared to
Munpolarized and a significant decrease of Ccr2 expression in
MLPS+IFN-y cells compared to Munpolarized and MIL-4+IL-13 cells
(Supplementary Figure 3C and Supplementary Table 2).
Signaling through chemokine receptors also contributes to
integrin activation (30) in a phenotype-dependent manner
(31, 32). We thus characterized surface expression of keyFIGURE 2 | MoC accumulation in the ChP during EAE. (A, B) Representative confocal images of the ChP from the third ventricle of (A) a healthy CX3CR1-GFP x
CCR2-RFP mouse and (B) from a CX3CR1-GFP x CCR2-RFP mouse induced with EAE (weight loss stage). RFP+ and GFP+ cells indicate the presence of CCR2+
MoCs and CX3CR1+ tissue resident cells respectively. Staining with DAPI reveals nuclei, PECAM-1-specific immunostaining reveals endothelial cells. Scale bar, 50
mm; magnified regions, scale bar 30 mm. (C) Density of RFP+ (CCR2+) and GFP+ RFPnegative cells (CX3CR1+CCR2negative) from the ChP of the third, fourth and lateral
ventricles of CX3CR1-GFP x CCR2-RFP mice at different EAE disease stages post immunization. Analysis includes 6 healthy control mice, 5 mice at preclinical
weight loss, 9 mice at clinical onset, 7 mice at symptomatic peak and 3 mice at clinical remission. Data is represented as mean ± SEM, one-way ANOVA with
Tukey´s multiple comparison test. A statistically significant increase in CCR2+ cell density in the ChP was observed at weight loss, compared to a healthy status,
p = 0.0463, *p < 0.05. (D) Representative confocal images of the ChP from the third ventricle of an iNOS-tdTomato x Arginase-EYFP mouse induced with EAE
(symptomatic peak). tdTomato indicates MiNOS, EYFP MArginase cells. Staining with DAPI reveals nuclei, immunostaining with PECAM-1-specific antibodies reveals
endothelial cells. Scale bar, 50 mm; magnified regions, scale bar 30 mm. (E) Density of MiNOS, MArginase and MiNOS/Arginase cells from the ChP of iNOS-tdTomato x
Arginase-EYFP mice at different disease stages (analysis includes 2 healthy control mice, 2 mice at weight loss, 5 mice at clinical onset, 6 mice at symptomatic peak,
3 mice at disease remission). Data is represented as mean ± SEM.April 2021 | Volume 12 | Article 666961
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(30, 33, 34) and observed high basal expression of b2, a4 and
b1 integrin subunits in all MoCs, with b2 integrin significantly
more expressed in MIL-4+IL-13 cells (35) (Supplementary
Figure 3D).
In conclusion, we tested in vitromodels of the BBB and of the
blood-CSF barrier which show mature barrier characteristics. In
parallel, we could observe that differential MoC polarization
significantly affects expression of key molecules involved in cell
dynamics, which may contribute to the different interaction of
MoCs with distinct CNS barriers.Functional Polarization Decreases
MoC Adhesion to the BBB
and Migration In Vitro
To study the migration of MoCs across CNS barriers, we used a
two-chamber transmigration system in which CMFDA-labelled
MoCs were co-incubated with BBB endothelial cells.
Using confocal microscopy, we observed that Munpolarized cells
adhered to the luminal side of unstimulated BBB endothelial cells
in a significantly higher number compared to polarized MoCs
(Figure 3A). This also resulted into higher presence of
transmigrated Munpolarized on the abluminal BBB endothelial
cell side compared to polarized cells (Figure 3B). Activation of
BBB endothelial cells with the pro-inflammatory cytokines TNF-
a+IFN-g or IL-1b further increased Munpolarized cell attachment
and diapedesis (Figures 3A, B).
Physiological shear flow within the vascular lumen plays a
critical role in immune cell migration (36). To mimic these
forces, we used an established live cell imaging approach (21) and
allowed MoCs to interact with BBB endothelial cells under
physiological flow conditions (1.5 dyn/cm2). In accordance to
our observations under static conditions, both MLPS+IFN-y and
MIL-4+IL-13 cells showed significantly reduced adhesion to BBB
endothelial cells compared to Munpolarized cells (Figure 3C).
Following their shear resistant arrest, Munpolarized cells started
to probe the BBB monolayer surface or to crawl over the luminal
side of BBB endothelial cells, both behaviors eventually leading to
diapedesis (Figure 3D).
Taken together, pro- or anti-inflammatory MoCs showed
reduced abilities to interact with the luminal surface of the
BBB, thus suggesting that infiltrating MoCs cannot become
fully functionally polarized at the luminal side of the BBB.Polarized MoCs Efficiently Interact With
the Blood-CSF Barrier Epithelium In Vitro
The ChP has been proposed as a key gateway for CNS-invading
immune cells (2, 37, 38). CCR2+ MoCs can accumulate in the
ChP stroma following extravasation across local fenestrated
capillaries and could subsequently cross the epithelial blood-
CSF barrier to enter the CSF. However, no formal demonstration
of this pathway exists in EAE and MS (24).
To mimic MoC dynamics at this CNS gateway, we used a two-
chamber transmigration assay allowing CMFDA-stainedFrontiers in Immunology | www.frontiersin.org 10Munpolarized, MLPS+IFN-y and MIL-4+IL-13 cells to interact with the
basolateral side of ChP epithelial cell monolayers cultured on
inverted filters, thus simulating the physiological orientation of
epithelial cells within the ChP (20). Interestingly, Munpolarized and
MIL-4+IL-13 cells adhered in significantly higher numbers to the
basolateral side of unstimulated ChP epithelial cells compared to
MLPS+IFN-y cells, while cytokine-stimulated ChP epithelial
cells allowed efficient adhesion of all Munpolarized, MLPS+IFN-y
and MIL-4+IL-13 cells (Figure 3E). Also, a comparable absolute
number of MLPS+IFN-y, MIL-4+IL-13 and Munpolarized cells could
move across the epithelial ChP epithelial cell monolayer
(Figure 3F).
Taken together, our in vitro observations suggest that the ChP
might constitute a permissive gateway potentially allowing CSF
access to MoCs.Differential Activation of CNS Barrier
Cells Primes MoCs Toward Distinct
Functional Fates
The accumulation of polarized MoCs at CNS barriers following
EAE induction suggests that invading MoCs can acquire a pro-
or anti-inflammatory phenotype early during the invasion
process. While a series of transcriptional and morphological
changes occurring in monocytes interacting with endothelial
cells have been described (39, 40), whether MoCs can acquire a
specific functional state during their interaction with CNS barrier
cells remains unclear.
To address this question, we analyzed the transcriptional
profile of Munpolarized cells incubated with BBB endothelial and
ChP epithelial cells activated by different inflammatory stimuli
present during EAE (41). Transcriptional analysis of barrier-
interacting MoCs revealed enhanced expression of genes
encoding for proteins participating in glycolysis, indicating an
increased metabolic activation (Supplementary Figure 4A–D
and Supplementary Table 3). A small increase in Il6 and Il6r
expression was observed in Munpolarized cells incubated with both
BBB endothelial and ChP epithelial cells (Supplementary Figure
4E, F); similarly, an increased (albeit not significantly) Mmp2
expression was detected in MoCs upon incubation with both
barriers (Supplementary Figure 4G, H and Supplementary
Table 3). Il1b showed a tendency toward upregulation
following Munpolarized incubation with ChP epithelial cells and a
significantly higher expression in MoCs interacting with IL-1b-
stimulated BBB endothelial cells (Supplementary Figure 4G, H
and Supplementary Table 3). Thus, interaction with CNS
barrier cells triggered a general cellular activation in
Munpolarized cells.
To understand whether these changes paralleled the
acquisition of a pro- or anti-inflammatory phenotype, we
analyzed expression of Nos2 and Arg1 in MoCs and observed
strongly increased (albeit not significantly) Nos2 expression in
Munpolarized cells incubated with TNF-a+IFN-g activated BBB
endothelial cells (Figure 4A and Supplementary Table 3).
Nos2 was instead significantly upregulated in Munpolarized cells
incubated with IFN-g stimulated ChP epithelial cells (Figure 4BApril 2021 | Volume 12 | Article 666961
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BBB endothelial cells led to a highly significant upregulation
of Arg1 (Figure 4A and Supplementary Table 3). Increased
Arg1 expression was also observed in MoCs incubated with
ChP epithelial cells in unstimulated and TNF-a stimulatedFrontiers in Immunology | www.frontiersin.org 11conditions, albeit at a lower level (Figure 4B and
Supplementary Table 3).
In conclusion, our data indicates that CNS barrier cells
regulate the balance between Nos2 and Arg1 expression and
thus trigger the acquisition of distinct pro- and anti-A B
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FIGURE 3 | MoC migration across BBB endothelial and ChP epithelial cells in vitro. (A, B) Munpolarized, MLPS+IFN-g and MIL-4+Il-13 cells were allowed to migrate across
a monolayer of unstimulated, IL-1b or TNF-a+IFN-g stimulated BBB endothelial cells in a two-chamber system. (A) Number of Munpolarized, MLPS+IFN-g and MIL-4+Il-13
cells attached on the luminal side of BBB endothelial cells following 8h incubation. Data points represent mean number of cells per filter, with five fields of view (FOV)
analysed per filter, four independent experiments (one experiment was performed in duplicates). Displayed are mean ± SEM, two-way ANOVA with Tukey´s multiple
comparison, *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001. On both unstimulated and cytokine activated BBB endothelial cells, Munpolarized cells attached with
higher efficiency compared to both MLPS+IFN-g and MIL-4+IL-13 (Munpolarized vs MLPS+IFN-g p < 0.0001; Munpolarized vs MIL-4+IL-13 p < 0.0001). Munpolarized attached more
to IL-1b BBB endothelial cells (p = 0.019) and TNF-a+IFN-g BBB endothelial cells (p = 0.006) as compared to unstimulated BBB endothelial cells. Compared to
MLPS+IFN-g, MIL-4+IL-13 cells adhered significantly more to IL-1b (p = 0.033) and TNF-a+IFN-g stimulated BBB endothelial cells (p = 0.005). (B) Number of MoCs which
migrated on the abluminal side of BBB endothelial cells after 8h incubation. Data points represent mean number of cells per filter, with five fields of view (FOV)
analysed per filter, four independent experiments (one experiment was performed in duplicates). Displayed are mean ± SEM, two-way ANOVA with Tukey´s multiple
comparisons test, *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001. A significantly higher number of Munpolarized cells underwent diapedesis across IL-1b stimulated
BBB endothelial cells compared to both MLPS+IFN-g (p < 0.0001) and MIL-4+Il-13 (p = 0.0057) cells. Munpolarized also showed increased migration across TNF-a+IFN-g
BBB endothelial cells compared to MLPS+IFN-g cells (p < 0.011). Compared to MLPS+IFN-g, MIL-4+IL-13 cells migrated in higher numbers across both IL-1b (p = 0.004)
and TNF-a+IFN-g BBB endothelial cells (p = 0.024). Within its group, Munpolarized cells migrated more efficiently through IL-1b compared to both unstimulated
(p =0.0001) and TNF-a+IFN-g BBB endothelial cells (p = 0.003). Polarized MoCs also show different migration efficiencies: MIL-4+IL-13 migrate in higher numbers
across IL-1b stimulated BBB endothelial cells than across unstimulated endothelium (p = 0.04). Additionally, MIL-4+IL-13 migrate in higher numbers across both IL-1b
BBB endothelial cells (p = 0.0035) and TNF-a+IFN-g BBB endothelial cells (p = 0.024) as compared to MLPS+IFN-g cells. (C) Munpolarized, MLPS+IFN-g and MIL-4+Il-13 cells
were allowed to migrate and interact with unstimulated, IL-1b and TNF-a+IFN-g stimulated BBB endothelial cells under physiological flow (1.5 dyn/cm2) for a period
of 25 minutes. Shown is the number of arrested cells on BBB endothelial cells per field of view (FOV). Munpolarized cells displayed superior abilities to adhere to both
IL-1b (Munpolarized vs MLPS+IFN-g p = 0.041; Munpolarized vs MIL-4+Il-13 p = 0.002) and TNF-a+IFN-g stimulated endothelial cells (Munpolarized vs MLPS+IFN-g p = 0.004;
Munpolarized vs MIL-4+IL-13 p = 0.003). (D) Migratory behaviour of Munpolarized cells on BBB endothelial cells under physiological flow conditions, during 25 minutes live
cell imaging. A significantly lower number of cells detached from the endothelium following attachment, compared to the cells that crawled or probed the monolayer
(unstimulated BBB endothelial cells: probing vs detachment p = 0.009, crawling vs detachment p = 0.009; IL-1b BBB endothelial cells: probing vs detachment p =
0.008; TNF-a+IFN-g BBB endothelial cells: probing vs detachment p = 0.013, crawling vs detachment p = 0.014). Displayed are the results from 4 independent
experiments, mean ± SEM shown, two-way ANOVA with Tukey´s multiple comparisons test, *p < 0.05, **p < 0.01. (E, F) Munpolarized, MLPS+IFN-g and MIL-4+Il-13 cells
were allowed to migrate across a monolayer of unstimulated, TNF-a or IFN-g stimulated ChP epithelial cells in a two-chamber system. (E) Numbers of Munpolarized,
MLPS+IFN-g, MIL-4+IL-13 adhering on the basolateral side of ChP epithelial cells following 8h incubation. Munpolarized and MIL-4+IL-13 display superior abilities to adhere to
unstimulated ChP epithelial cells compared to MLPS+IFN-g cells (Munpolarized vs MLPS+IFN-g p = 0.03; MIL-4+IL-13 vs MLPS+IFN-g p = 0.017). Data points represent mean
number of cells per filter, with five fields of view (FOV) analysed per filter, four independent experiments. Displayed are mean ± SEM. Two-way ANOVA with Tukey´s
multiple comparisons test, *p < 0.05. (F) Number of MoCs that migrated toward the apical side of ChP epithelial cells. No statistically significant differences were
detected between conditions. Data points represent mean number of cells per filter, with five fields of view (FOV) analysed per filter, four independent experiments.
Displayed are mean ± SEM.
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stimulus-dependent manner.
Endothelial Derived GM-CSF Aids Arg1
Expression in BBB-Interacting MoCs
To define the molecular mechanism behind anti-inflammatory
polarization of MoCs at CNS barriers, we investigated factors
secreted by Arg1-inducing IL1b-stimulated BBB endothelial cells
(Figure 4A) and observed in these cells selective upregulation of
Csf3, encoding for granulocyte colony-stimulating factor (G-
CSF) and Csf2, encoding for granulocyte-macrophage colony-
stimulating factor (GM-CSF) (Figure 4C and Supplementary
Table 4). Activated endothelial cells release high amounts of G-
CSF (42) and GM-CSF (41, 43–45), with these cytokines detected
in both MS patients and EAE CNS tissue (46–48). G-CSF and
GM-CSF are growth factors able to induce monocyte/
macrophage proliferation (49), but their effect on MoC
functions remains controversial (43, 50–52).
To understand the role of endothelial-derived G-CSF and
GM-CSF on MoC functional polarization, we supplemented
neutralizing antibodies against G-CSF and GM-CSF during the
interaction of Munpolarized cells with IL-1b stimulated BBB
endothelial cells and observed a non-significant decrease of
Arg1, Tpi1 and Gpi1 expression in Munpolarized cells upon
blocking (Figure 4D and Supplementary Table 5). In parallel,
to assess the direct effect of GM-CSF and G-CSF on MoCs, we
incubated these factors with Munpolarized cells and observed that
GM-CSF, but not G-CSF, consistently triggered (albeit notFrontiers in Immunology | www.frontiersin.org 12significantly) Arg1 upregulation in Munpolarized cells (Figure 4E
and Supplementary Table 6).
Taken together, our in vitro experiments suggest that GM-
CSF secreted by IL-1b stimulated endothelial cells could only in
part contribute to the acquisition of an arginase-1+ phenotype in
interacting MoCs.
IL-1b Signaling in BBB Endothelial Cells
Regulates Arginase-1 Expression in MoCs
The induction of pro- and anti-inflammatory genes in MoCs
interacting with CNS barrier cells suggests that the migration of
MoCs across CNS borders can directly regulate the phenotype of
invading MoCs. To understand whether IL-1b signaling in BBB
cells triggers the expression of arginase-1 in MoCs as observed in
vitro, we induced EAE in VE-cadherin-GFP x iNOS-tdTomato x
Arginase-EYFP mice and immune-stained spinal cord sections
with IL-1b receptor (IL1R1)-specific antibodies. As suggested by
a previous report (41), we observed diffuse IL1R1
immunostaining in the leptomeningeal vasculature, whereas a
lower proportion of IL1R1+ vasculature could be detected in the
inflamed spinal cord parenchyma (Figure 5A). Secondly, we
compared the density and distribution of MiNOS, MArginase and
MiNOS/Arginase cells lining IL1R1+ or IL1R1negative vasculature
within spinal cord lesions. Given their position, we assumed
that analyzed MoCs recently reached the CNS following
interaction with proximal endothelial cells. Interestingly, while
IL1R1negative vasculature showed a statistically higher presence of
MiNOS compared to MArginase cells, IL1R1+ vasculature wasApril 2021 | Volume 12 | Article 666961
Ivan et al. CNS Barriers Induce Macrophage Polarizationsurrounded by an equal number of MiNOS and MArginase cells.
Compared to MArginase cells however, transitional MiNOS/Arginase
cells accumulated more densely around all vessels (Figures
5B, C).Frontiers in Immunology | www.frontiersin.org 13Taken together, both our in vitro and in vivo observations
support a role of IL-1b signaling in endothelial cells in the
regulation of MoC functional specifications during
CNS invasion.A B C
D E
FIGURE 4 | Interaction with BBB endothelial and ChP epithelial cells drives functional specification in MoCs. Relative mRNA expression of Nos2 and Arg1 genes in
Munpolarized MoCs following 7h incubation with (A) BBB endothelial cells and (B) ChP epithelial cells. (A) Incubation with TNF-a+IFN-g BBB endothelial cells led to
Nos2 upregulation in MoCs (Munstimul.Endothelium Mean = 1.74, SEM = 0.37; MIL-1b Endothelium Mean = 2.74, SEM = 1.12; MTNF-a+IFN-g Endothelium Mean = 20.26, SEM =
10.6). In contrast, Arg1 relative mRNA expression was significantly increased in MoCs incubated with IL-1b BBB endothelial cells (MIL-1b Endothelium) as compared to
Munpolarized cells (p < 0.0001), to Munstimulated Endothelium (p = 0.0001) and MTNF-a+IFN-g Endothelium (p = 0.0003). (B) MoCs incubated with IFN-g stimulated ChP epithelial
cells (MIFN-g Epithelium) significantly upregulated Nos2 relative mRNA expression compared to Munpolarized (p = 0.013), to Munstimulated Epithelium (p = 0.014) and to MTNF-a
Epithelium (p = 0.018). Similarly, MoCs incubated with unstimulated ChP epithelial cells (Munstimulated Epithelium) (p = 0.007) or with TNF-a ChP epithelial cells (MTNF-a
Epithelium) (p = 0.01) displayed increased Arg1 mRNA expression. (C) mRNA expression of Csf2 and Csf3 in BBB endothelial cells. Following 16h of IL-1b stimulation,
BBB endothelial cells displayed a significantly increased Csf2 (one way ANOVA – F (2,6) = 8.97, p = 0.02) and Csf3 relative mRNA expression (one way ANOVA – F
(2, 6) = 5.203, p = 0.05) compared to unstimulated and TNF-a+IFN-g BBB endothelial cells. The relative mRNA expression of Nos2 and Arg1 was calculated based
on the 2-DDCt method using S16 (A, B) or Hprt (C) as reference genes. Data is presented as fold increase relative to Munpolarized condition (A, B) or to unstimulated
condition (C); displayed are means and SEM from three individual experiments, *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001. A mean of the raw cycle
threshold (Ct) values from the independent experiments performed are provided in Supplementary Table 3 and 4. (D) mRNA expression of Arg1, Tpi1 and Gpi1
genes in MoCs following 7h incubation with BBB endothelial cells or ChP epithelial cells in the presence or absence of G-CSF and GM-CSF neutralizing antibodies.
G-CSF + GM-CSF neutralizing antibodies (10µg/ml each) or isotype control (20µg/ml) were supplemented to MoCs incubated with BBB endothelial cells or ChP
epithelial cells. A non-significant decrease in Arg1, Tpi1 and Gpi1 mRNA expression was observed in MoCs following blocking of G-CSF and GM-CSF in IL-1b BBB
endothelial cells (Arg1: IL-1bIsotype Mean = 7.80, SEM = 3.29; IL-1bG-CSF+GM-CSF Mean = 5.34, SEM = 1.45; Tpi1: IL-1bIsotype Mean = 1.15, SEM = 0.02; IL-1bG-CSF
+GM-CSF Mean = 0.97, SEM = 0.12; Gpi1: IL-1bIsotype Mean = 1.21, SEM = 0.11; IL-1bG-CSF+GM-CSF Mean = 0.69, SEM = 0.23). Target genes were normalized to the
reference gene S16 and the data is presented as fold increase relative to the unstimulated condition (2-DDCt). Displayed are means ± SEM from technical triplicates, 4
independent experiments. Raw cycle threshold (Ct) values from the independent experiments performed are provided in Supplementary Table 5. (E) Arg1 relative
mRNA expression in MoCs incubated for 7h with recombinant mouse G-CSF or GM-CSF proteins at different concentrations (10ng/ml, 50ng/ml or 100ng/ml). An
increase in Arg1 expression was observed upon MoC incubation with GM-CSF (MoCs + 10ng Mean = 7.48, SEM = 4.36; MoCs + 50ng Mean = 9.0, SEM = 4.95;
MoCs + 100ng Mean = 7.42, SEM = 3.71). Target genes were normalized to the reference gene Hprt and data presented as fold increase relative to the
unstimulated condition (2-DDCt). Displayed are means ± SEM from technical triplicates, 3 independent experiments. Raw cycle threshold (Ct) values from the
independent experiments performed are provided in Supplementary Table 6.April 2021 | Volume 12 | Article 666961
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CNS inflammation as observed in MS and in EAE drives the
mobilization of monocytes from the bone marrow to the
bloodstream (53, 54), with cells accessing the CNS at the level
of the BBB, the blood-CSF barrier, or at the subarachnoid
vasculature within the leptomeninges (1). Accumulation of
MoCs at CNS borders is thus a key event in disease
development (23, 55). While the study of immune cell
migration through distinct CNS access gateways has
considerably increased the efficacy of MS treatments (56),
research has however largely focused on lymphocyte dynamics
(57–59), with the trafficking routes of circulating monocytes
during neuroinflammation remaining surprisingly unclear (24).
Furthermore, the anatomical sites and the mechanisms leading
to the acquisition of pro- or anti-inflammatory specifications in
CNS-invading MoCs have not been properly investigated.Frontiers in Immunology | www.frontiersin.org 14In this study, we used bone marrow-derived Munpolarized, MLPS
+IFN-y andMIL-4+IL-13 cells to model the distinct in vivo functional
features of MoCs and to assess their interaction and
transmigration properties with in vitro BBB endothelial and
blood-CSF barrier epithelial cells.
Activation of endothelial cells augmented adhesion and
diapedesis of Munpolarized cells, suggesting that inflammation
increases the extravasation of MoCs as shown for other
immune cells (21, 60, 61). While inflammatory conditions
decreased endothelial TEER implying impaired barrier
properties, junctional continuity remained largely intact, in line
with the notion that BBB physical disruption is not strictly
needed for cell extravasation (62).
Notably, polarization of MoCs toward pro-inflammatory
MLPS+IFN-y or anti-inflammatory MIL-4+IL-13 states drastically
reduced cellular adhesion to endothelial cells, in line with
previous data showing that functionally-committed MoCs areA B
C
FIGURE 5 | Polarized MoC density around IL1R1+ and IL1R1negative vasculature during EAE. (A) Relative percentage of IL1R1+ and IL1R1negative vessels in the
inflamed spinal cord parenchyma (n=6) and leptomeninges (n=5) of VE-cadherin-GFP x iNOS-tdTomato x Arginase-EYFP mice induced with EAE (3 days after
disease onset). A higher number of IL1R1+ vessels were detected in the meninges compared to parenchyma, unpaired t test (p=0.018, *p < 0.05). The total amount
of vessels in tissue sections was assessed using the GFP positivity of VE-Cadherin expressing endothelial cells. Immunostaining with IL1R1-specific antibody
revealed receptor expression. (B) Density of MiNOS, MArginase and MiNOS/Arginase cells surrounding IL1R1+ and IL1R1negative vasculature of VE-cadherin-GFP x iNOS-
tdTomato x Arginase-EYFP mice induced with EAE (6 mice, 3 days after disease onset). The quantified areas include tissue at a maximum distance of 20 µm from
the endothelial GFP signal. Data represented as mean ± SEM. In the proximity of IL1R1+ vessels, a higher density of MiNOS/Arginase cells (Mean = 4389, SEM = 933.6)
are detected as compared to MArginase (Mean = 1321, SEM = 650.9) (p = 0.136) and to MiNOS (Mean = 2254, SEM = 490.6) (p = 0.105). In contrast, in the proximity
of IL1R1negative vessels, a higher number of MiNOS (Mean = 3352, SEM = 906.1) (p=0.048) and MiNOS/Arginase cells (Mean = 3556, SEM = 812.3) (p=0.031) are
detected as compared to MArginase cells (Mean = 839.6, SEM = 258.0). Two-way ANOVA with Tukey´s multiple comparisons test, *p < 0.05, ns, not significant.
(C) Representative confocal images of spinal cord tissue from VE-cadherin-GFP x iNOS-tdTomato x Arginase-EYFP mice induced with EAE (3 days after disease
onset). tdTomato indicates MiNOS, EYFP MArginase cells and GFP VE-cadherin expression at BBB endothelial cell junctions. Immunostaining with IL1R1-specific
antibody reveals IL1R1 receptor expression. Arrowheads highlight MArginase cells and arrows indicate MiNOS cells in the perivascular space and in the tissue
surrounding the vessel. Scale bar, 50 mm; magnified regions, scale bar 30 mm.April 2021 | Volume 12 | Article 666961
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(17). The observed downregulation of Ccr2 might contribute to
the reduced adhesion and migration of MLPS+IFN-y cells (63, 64).
Interestingly, a similar downregulation of Ccr2 in iNOS+ pro-
inflammatory CNS-invading macrophages was observed during
EAE (data not shown) (17). Nonetheless, despite similar
chemokine receptor levels and increased b2 integrin expression
compared to Munpolarized cells, also MIL-4+IL-13 cells failed to
efficiently interact with BBB endothelial cells. Other adhesion
factors, signaling molecules and physical characteristics can thus
affect the dynamics of MoCs at the BBB, but the overall
mechanism remains unclear.
While the acquisition of a full functional specification is not
a pre-requisite for MoC extravasation at the BBB, subsequent
accumulation in the perivascular space seems associated with a
preferential pro-inflammatory glycolytic state in MoCs, as
shown in both EAE and MS (17, 65). Crossing of activated
endothelial cells towards the perivascular space milieu might
therefore represent a key step in the functional priming of
MoCs before invasion of the CNS parenchyma. By analyzing
macrophage distribution in the VE-cadherin-GFP x iNOS-
tdTomato x Arginase-EYFP model upon EAE induction, we
could accordingly observe an increased accumulation of pro-
inflammatory MiNOS cells in spinal cord perivascular spaces
compared to other CNS interfaces such as leptomeninges and
ChP stroma. Notably, in a different series of in vitro
experiments, Nos2 expression could be specifically induced
(albeit not significantly) in Munpolarized cells by IFN-g-
stimulated BBB endothelial cells. This observation suggests
that, in an IFN-g (T cell-) dominated inflammatory context,
passage through the BBB can aid priming of MoCs toward a
pro-inflammatory state.
Once accumulating in the CNS however, MiNOS cells evolve
their phenotype by upregulating Arg1 expression and becoming
MiNOS/Arginase cells (17). Furthermore, distinct MArginase cells
invade the CNS parenchyma without previously expressing
Nos2 (17). Several factors might be responsible for driving
Arg1 expression and the phenotypic change in MiNOS cells,
including astrocyte-secreted molecules (17). Our in vitro work
now showed that IL-1b signaling in BBB endothelial cells is a key
driver of Arg1 expression in CNS-infiltrating MoCs.
Accordingly, analysis of parenchymal lesions in the EAE model
indicated that MoCs accumulate in different proportions nearby
IL1R1+ vessels compared to IL1R1negative vessels. At the same
time, a slightly increased presence of “phenotype-shifting”
MiNOS/Arginase cells compared to perivascular spaces could be
observed in the leptomeninges, a compartment characterized by
higher density of IL1R1+ vasculature.
Taken together, depending on the anatomical location and
on the activation of the BBB endothelial cells encountered
during migration, MoCs can be primed toward an iNOS+ pro-
inflammatory or arginase-1+ anti-inflammatory state while
accumulating at this CNS barrier. Moreover, our in vitro
model suggests that the production of GM-CSF by an IL-1b
activated endothelium might contribute to the Arg1 expression
observed in MoCs, however not exclusively. GM-CSF releaseFrontiers in Immunology | www.frontiersin.org 15by IL-1b activated CNS endothelial cells was previously
reported to enhance CCR2+ MoC act ivat ion (43) .
Upregulation of arginase-1 by recombinant GM-CSF in
MoCs has also been described (66), but the connection
between these signaling axes during neuroinflammation was
not established. While the GM-CSF-mediated upregulation of
the anti-inflammatory gene Arg1 appears somewhat in contrast
wi th the d i sease -dr iv ing func t ion of GM-CSF in
neuroinflammatory models (67, 68), MoCs stimulated with
GM-CSF have been described as cells sharing pro- and anti-
inflammatory characteristics (50–52), with a recent work even
proposing that exposure to GM-CSF can lead to the formation
of monocyte-derived suppressor cells (69).
Functional polarization could also be triggered by the
interaction of MoCs with primary ChP epithelial cells.
Similar to what observed with the BBB model, IFN-g
stimulation allowed ChP epithelial cells to drive Nos2
expression in MoCs, while Arg1 was induced following MoC
interaction with unstimulated and TNF-a stimulated epithelial
cells, and less strongly by IFN-g stimulated epithelial cells. In
contrast with what we observed at the BBB however,
Munpolarized and polarized MIL-4+IL-13 and MLPS+IFN-y
macrophages could efficiently adhere to and move across
ChP epithelial cells. Taken together, these experiments
suggested that the blood-CSF barrier could constitute a CNS
access gateway and a priming site for both pro- and anti-
inflammatory MoCs. Nonetheless, when analyzing brain
sections from mice induced with EAE, only low numbers of
iNOS+/arginase-1+ MoCs could be observed in situ, compared
to the high density of CCR2+ MoCs detected within the ChP.
Thus, local acquisition of an overt pro- or anti-inflammatory
phenotype can happen within the ChP stroma, but remains a
minor phenomenon compared to the recruitment of yet-to-be-
polarized MoCs. Intravital studies are still crucially needed to
shed light on the real MoC dynamics at the secluded ChP.
In conclusion, our work sheds light on the dynamics of MoC
recruitment at the different borders of the CNS during
neuroinflammation. Collectively, our data indicate that local
signaling cues and interaction between MoCs and CNS barrier
cells can significantly shape the function of invading cell and thus
affect the pathological and clinical evolution of autoimmune
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Supplementary Figure 1 | Primary Mouse Brain Microvascular Endothelial Cells
characterisation. BBB endothelial cells were isolated from C57BL/6J male mice and
stimulated with 20ng/ml IL-1b or with 5ng/ml TNF-a +100IU/ml IFN-g. Unstimulated
BBB endothelial cells were used as control. (A–D) Immunofluorescence stainings of
adherens junction molecules b-catenin (A) and VE-cadherin (B) and of the tight
junction molecules ZO-1 (C) and claudin-5 (D), scale bar 50mm. Pictures are
representative of three independent experiments. (E–J) Immunofluorescence
stainings of ICAM-1 (E), VCAM-1 (F) and E-selectin (G) in unstimulated, IL-1b and
TNF-a+IFN-g stimulated BBB endothelial cells at culture day seven. Pictures are
representative of three independent experiments, 50mm scale bar. (H–J)
Quantification of mean fluorescence intensity of ICAM-1, VCAM-1 and E-selectin
immunofluorescence stainings of the BBB endothelial monolayer performed using
ImageJ software. (H) ICAM-1 expression is significantly upregulated in IL-1b BBB
endothelial cells compared to both unstimulated (p=0.005) and TNF-a+IFN-g BBB
endothelial cells (one-way ANOVA p=0.007) (n=2). (I) VCAM-1 mean fluorescence
intensity is higher on both IL-1b (Mean = 27.82, SEM = 2.58) and TNF-a+IFN-g
(Mean = 26.15, SEM = 3) BBB endothelial cells (one-way ANOVA F (2,6) = 2.504,
p= 0.162) (n=3). (J) E-selectin mean fluorescence intensity is significantly
upregulated in IL-1b BBB endothelial cells compared to both unstimulated (one-
way ANOVA, p=0.004) and TNF-a+IFN-g BBB endothelial cells (one-way ANOVA,
p=0.005) (n=3). (K) Tightness of BBB endothelial cells cultured on 5mm pore size
filters was determined by TEER (W*cm2). Data is presented as mean and standard
error of the mean (SEM) from five independent experiments. TEER of stimulatedFrontiers in Immunology | www.frontiersin.org 16BBB endothelial cells is significantly lower compared to unstimulated endothelium
(one-way ANOVA, F (2,42) = 35.86, p < 0.0001).
Supplementary Figure 2 | Characterization of Primary Mouse Choroid Plexus
Epithelial Cells. ChP epithelial cells were isolated from lateral, 3rd and 4th brain
ventricles of C57BL/6J male mice and at culture day 6 were stimulated with 10ng/
ml TNF-a or with 100IU/ml IFN-g for 16h. Unstimulated ChP epithelial cells were
used as control condition. Shown are immunofluorescence stainings of adherens
junction molecules E-cadherin (A), b-catenin (B) and tight junction molecule
junctional adhesion molecule-A (JAM-A) (C) expressed on unstimulated and TNF-a
or IFN-g stimulated ChP epithelial cells at culture day seven. Pictures are
representative of two independent experiments for ICAM-1 and one experiment for
VCAM-1, scale bar 50mm. (D, E) Surface expression of ICAM-1 and VCAM-1 in
unstimulated and TNF-a or IFN-g stimulated ChP epithelial cells at culture day
seven, representative images from 2 experiments (ICAM-1) and one experiment
(VCAM-1). (F, G) Quantification of the mean fluorescence intensity of ICAM-1 and
VCAM-1 immunofluorescence stainings of ChP epithelial monolayer performed
using ImageJ software. Both ICAM-1 (n=2) and VCAM-1 (n=1) are upregulated in
IFN-g ChP epithelial cells compared to unstimulated and TNF-a conditions (ICAM-1
Unstimulated vs IFN-g stimulated ChP epithelial cells p = 0.035, one way ANOVA).
(D) Tightness of ChP epithelial cells cultured on 5mm pore size filters was
determined by TEER (W*cm2). No statistically significant differences were detected
between conditions, one-way ANOVA, four independent experiments.
Supplementary Figure 3 | Bone marrow-derived macrophages were isolated
from C57BL/6J male mice and stimulated with 100ng/ml LPS + 10ng/ml IFN-g
(MLPS+IFN-g) or with 10ng/ml IL-4 + 10ng IL-13 (MIL-4+IL-13). Munpolarized cells were
left unstimulated. (A–C) Gene expression was assessed by RTqPCR following
mRNA extraction and cDNA synthesis. Data was normalized using Hprt as
reference gene and presented as fold increase relative to Munpolarized condition (2-
DDCt, see Methods). Raw cycle threshold (Ct) values from the independent
experiments performed are provided in Supplementary Table 2. (A) mRNA
expression of pro-inflammatory genes Nos2, Fpr2, Gpr18, Cd38, Cd86, Stat1
and of (B) anti-inflammatory genes Retnla, Arg1, Mrc1, Ym1 and Egr2 is shown.
Displayed are means ± SEM obtained from technical triplicates, 3 independent
experiments; one-way ANOVA analysis with Tukey´s multiple comparisons test.
MLPS+IFN-g compared to MIL-4+Il-13 and to Munpolarized cells have a significantly
higher expression of Nos2 (F (2,18) = 4.677, p = 0.023), Fpr2 (F (2,6) = 6.587, p =
0.031), Cd38 (F (2,6) = 46.46, p =0.0002), Cd86 (F (2,6) = 114.5, p < 0.0001),
Stat1 (F (2,6) = 63.48, p < 0.0001), Gpr18 (F (2,6) = 4.012, p < 0.078). Compared
to Munpolarized and MLPS+IFN-g macrophages, MIL-4+IL-13 cells display significantly
higher expression of Retnla (F (2,3) = 1.163, p = 0.423), Arg1 [F (2,18) = 22.13,
p < 0.0001], Ym1 (F (2,6) = 3.120, p = 0.117) Egr2 (F (2,6) = 12.68, p = 0.007) and
Mrc1 (one-way ANOVA, F (2,6) = 30.89, p = 0.007). (C) Relative expression of
Ccr1, Ccr2 and Ccr5 in Munpolarized, MLPS+IFN-g, MIL-4+Il-13 cells after 48h cytokine
stimulation. A statistically significant increase in Ccr1 expression was observed in
MLPS+IFN-g compared to Munpolarized cells (Tukey´s test: p = 0.03). Conversely,
MLPS+IFN-g displayed significantly downregulated Ccr2 expression compared to
Munpolarized cells (Tukey´s test: p = 0.001) and to MIL-4+IL-13 cells (Tukey´s test: p =
0.01). Displayed are mean ± SEM from 3 independent experiments. (D) Surface
expression of b2, a4 and b1 integrin molecules detected on Munpolarized, MLPS+IFN-g
and MIL-4+Il-13 macrophages by flow cytometry. MIL-4+Il-13 display a significantly
increased b2 integrin expression compared to MLPS+IFN-g and Munpolarized cells (one-
way ANOVA, F (2,3) = 14.92, p = 0.0276). Displayed are relative mean fluorescence
intensity (MFI) values obtained by subtracting the MFI of stained samples from the MFI
of isotype control-stained samples; data is presented as mean ± SEM from 2
independent experiments for b2 integrin and from 4 independent experiments for a4
and b1 integrins.
Supplementary Figure 4 | The influence of BBB endothelial and ChP epithelial
cells on MoC activation. MoCs were incubated with BBB endothelial cells and ChP
epithelial cells for 7h and afterwards, they were recovered from the monolayers and
their mRNA was isolated. Shown are relative mRNA expressions of Tpi1, Gpi1 (A,
B), Aldoa, Pfkl (C, D), Il6, Il6r (E, F), Mmp2 and Il1b (G, H) genes. Data was
normalized using Hprt as reference gene and is presented as fold increase relative
to Munpolarized condition (2-DDCt, see Methods). Displayed are means ± SEM
obtained from technical triplicates, 3 independent experiments, one-way ANOVA
analysis with Tukey´s multiple comparison. (A, C, E, G) MoCs incubated withApril 2021 | Volume 12 | Article 666961
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following genes as compared to Munpolarized cells: (A) Tpi1 - F (3, 8) = 9.492, p =
0.0052 (Tukey´s test: Munpolarized vs MIL-1b Endothelium p = 0.004; Munpolarized vs
MTNF-a+IFN-g Endothelium p = 0.0178); Gpi1 - F (3, 8) = 11.45, p = 0.0029 (Tukey´s test:
Munpolarized vs MUnstimulated Endothelium p = 0.0449; Munpolarized vs MIL-1b Endothelium p =
0.0018; Munpolarized vs MTNF-a+IFN-g Endothelium p = 0.029); (C) Aldoa - F (3, 8) = 6.105,
p = 0.018 (Tukey´s test: Munpolarized vs MIL-1b Endothelium p = 0.0225); (E) Il6r - F (3,
8) = 4.467, p = 0.04 (Tukey´s test: Munpolarized vs MIL-1b Endothelium p = 0.047); (G) Il1b
- F (3, 8) = 7.009, p = 0.0125 (Tukey´s test: Munpolarized vs MIL-1b Endothelium p =
0.0132). Additionally, statistically significant differences were found in Il1b (p =
0.028) and Aldoa (p = 0.038) gene expressions between Munstimulated Endothelium
vs MIL-1b Endothelium. Pfkl, Il6 andMmp were also increased in MoCs upon incubation
with BBB endothelial cells, however statistical significance was not reached.
(B, D, F, H) Following MoC incubation with ChP epithelial cells, we observed the
following changes in gene expression: compared to Munpolarized cells, MoCs
incubated with cytokine activated ChP epithelial cells showed an increased mRNAFrontiers in Immunology | www.frontiersin.org 17expression in (B) Tpi1 - F (3, 8) = 10.36, p = 0.004 (Tukey´s test: Munpolarized vs
Munstimulated Epithelium p = 0.0045; Munpolarized vs MTNF-a Epithelium p = 0.0292;
Munpolarized vs MIFN-g Epithelium p = 0.008);Gpi1 - F (3, 8) = 10.46, p = 0.0038 (Tukey´s
test: Munpolarized vs Munstimulated Epithelium p = 0.0049; Munpolarized vs MTNF-a Epithelium
p = 0.0063; Munpolarized vs MIFN-g Epithelium p = 0.0458); (D) Pfkl - F (3, 8) = 5.186,
p = 0.028 (Tukey´s test: Munpolarized vs Munstimulated Epithelium p = 0.032; Munpolarized
vs MTNF-a Epithelium p = 0.046). (D) Aldoa, (F) Il6r and (H)Mmp2 were also increased
in MoCs upon incubation with ChP epithelial cells, however statistical significance
was not reached. Raw cycle threshold (Ct) values from the independent
experiments performed are provided in Supplementary Table 3.
Supplementary Tables 1–6 | Fiji Macro used for the automatic quantification of
macrophages attached on the luminal side of BBB endothelial cells or on the upper
side of ChP epithelial cells filters in vitro. Fiji Macro used for the automatic
quantification of CX3CR1+ and CCR2+ cells in the choroid plexus ofCX3CR1-GFP x
CCR2-RFP mice.REFERENCES
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